论文部分内容阅读
目的 探讨肝门部胆管癌合理选择治疗方式。方法 对 3 4例患者按不同的治疗方式分为根治性切除 ,姑息性切除 ,胆肠内引流 ,金属支架内引流和外引流 5组 ,分析各种治疗方式与病变分型 ,生存时间和并发症的关系。结果 生存时间 ,根治性切除组 3 .3年 ;姑息性切除组平均2 0个月 ;胆肠内引流组平均 13个月 ;金属支架内引流组平均 12个月 ;外引流组 6.3个月。总并发症 2 3 .5 %。手术死亡率 0。结论 肝门部胆管癌的治疗应首选根治性切除 ,选择性的肝段切除是更合适的 ,姑息性切除的疗效优于各种内外引流术 ,胆肠吻合内引流术和金属支架内引流疗效相似。
Objective To explore the rational choice of treatment for hilar cholangiocarcinoma. Methods Thirty-four patients were divided into radical resection, palliative resection, biliary and intestinal drainage, metal stent internal drainage and external drainage according to different treatment methods. Various treatment methods and lesion classification, survival time and concurrence were analyzed. Relationship. Results The survival time was 3-5 years in the radical resection group, 20 months in the palliative resection group, 13 months in the gallbladder intestine drainage group, 12 months in the metal stent drainage group, and 6.3 months in the external drainage group. The total complication was 23.5%. Surgical mortality 0. Conclusions Radical resection should be the first choice in the treatment of hilar cholangiocarcinoma, and selective hepatectomy should be more appropriate. The efficacy of palliative resection is better than that of internal and external drainage, drainage in biliary-enteric anastomosis and drainage in metal stents. similar.